Repurposing colchicine's journey in view of drug-to-drug interactions. A review

Toxicol Rep. 2021 Jul 9:8:1389-1393. doi: 10.1016/j.toxrep.2021.07.009. eCollection 2021.

Abstract

Colchicine's medical evolution is historically bound to the Mediterranean basin, since remarkable researchers from this region underscored its valuable properties. With the passing of years colchicine became an essential pharmaceutical substance for the treatment of rheumatologic and cardiovascular diseases. In light of recent findings, the therapeutic value of colchicine has grown. In clinical practice, colchicine remains underutilized in view of its proven efficacy and safety. Its complex pharmacokinetics and multifaceted anti-inflammatory role remain under investigation. The current review addresses the safe administration of colchicine in view of key drug to drug interactions. Finally, we are briefly presenting colchicine's future potential applications.

Keywords: ACS, acute coronary syndrome; CAD, coronary artery disease; COVID-19, coronavirus disease - 19; Colchicine; DOACs, direct oral anticoagulants; History; Inflammation; Lp-PLA2, Lipoprotein-associated phospholipase A2; NLRP3, NOD-, LRR- and pyrin domain-containing protein 3; Pharmacokinetics; ROCK, Rho-associated protein kinase; Repurposing; Safety; eGFR, estimated glomerular filtration rate.